World's Best Scientists 2026 revealed!
Elisabeth A. M. Sanders

Elisabeth A. M. Sanders

D-Index & Metrics

Immunology

D-Index
81
Citations
23269
World Ranking
1570
National Ranking
59

Elisabeth A. M. Sanders publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Elisabeth A. M. Sanders sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 354 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Elisabeth A. M. Sanders D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Elisabeth A. M. Sanders sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 81 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Elisabeth A. M. Sanders is affiliated with Utrecht University in the Netherlands. Their research primarily lies within the field of Medicine, with a focus on Epidemiology, Microbiology, Infectious Diseases, Pulmonary and Respiratory Medicine, and Molecular Biology.

They have contributed extensively to topics including Pneumonia and Respiratory Infections, Respiratory Viral Infections Research, Bacterial Infections and Vaccines, Influenza Virus Research Studies, Gut Microbiota and Health, Vaccine Coverage and Hesitancy, and SARS-CoV-2 and COVID-19 Research.

Recent notable papers include:

  • "Effects of early-life antibiotics on the developing infant gut microbiome and resistome: a randomized trial" (2022, Nature Communications)
  • "Mother-to-infant microbiota transmission and infant microbiota development across multiple body sites" (2023, Cell Host & Microbe)
  • "Persistence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 in Relation to Symptoms in a Nationwide Prospective Study" (2021, Clinical Infectious Diseases)
  • "Early-life viral infections are associated with disadvantageous immune and microbiota profiles and recurrent respiratory infections" (2022, Nature Microbiology)
  • "Pneumococcal conjugate vaccines for preventing acute otitis media in children" (2020, Cochrane Database of Systematic Reviews)

Frequent co-authors include:

  • Marlies A. van Houten
  • Debby Bogaert
  • Nynke Y. Rots
  • Guy A. M. Berbers
  • Krzysztof Trzciński

Sanders has published frequently in the following venues:

  • Vaccine
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Infectious Diseases
  • SSRN Electronic Journal
  • The Journal of Infectious Diseases

Their work addresses key areas in infectious disease research, particularly focusing on the early-life development of microbiota, immune responses, vaccine efficacy, and respiratory infections. The intersection of microbiology and epidemiology is a significant aspect of their research profile, highlighting dynamics between microbial colonization and human health outcomes.

Best Publications

  • Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults

    Marc J.M. Bonten;Susanne M. Huijts;Marieke Bolkenbaas;Chris Webber

  • Viral and bacterial interactions in the upper respiratory tract.

    Astrid A. T. M. Bosch;Giske Biesbroek;Krzysztof Trzcinski;Elisabeth A. M. Sanders

  • Early Respiratory Microbiota Composition Determines Bacterial Succession Patterns and Respiratory Health in Children

    Giske Biesbroek;Evgeni Tsivtsivadze;Elisabeth A M Sanders;Roy Montijn

  • Association of Serotype with Risk of Death Due to Pneumococcal Pneumonia: A Meta-Analysis

    Daniel M. Weinberger;Zitta B. Harboe;Elisabeth A. M. Sanders;Moses Ndiritu

  • Otitis media and its consequences: beyond the earache

    Anne Vergison;Ron Dagan;Adriano Arguedas;Jan Bonhoeffer

  • Nasopharyngeal Microbiota, Host Transcriptome and Disease Severity in Children with Respiratory Syncytial Virus Infection.

    Wouter A. A. de Steenhuijsen Piters;Santtu Heinonen;Raiza Hasrat;Eleonora Bunsow

  • Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study

    Reinier Veenhoven;Debby Bogaert;Cuno Uiterwaal;Carole Brouwer

  • Maturation of the Infant Respiratory Microbiota, Environmental Drivers and Health Consequences: A Prospective Cohort Study

    Astrid A T M Bosch;Wouter Antonius Adrianus de Steenhuijsen Piters;Marlies A van Houten;Mei Ling J N Chu

  • The role of the local microbial ecosystem in respiratory health and disease

    Wouter A A de Steenhuijsen Piters;Elisabeth A M Sanders;Debby Bogaert

  • Negative attitude of highly educated parents and health care workers towards future vaccinations in the Dutch childhood vaccination program.

    Eelko Hak;Y Schönbeck;H De Melker;G A Van Essen

  • CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia

    Joris M. van Montfrans;Andy I.M. Hoepelman;Sigrid Otto;Marielle van Gijn

  • Development of Upper Respiratory Tract Microbiota in Infancy is Affected by Mode of Delivery.

    Astrid A.T.M. Bosch;Evgeni Levin;Marlies A. van Houten;Raiza Hasrat

  • Pneumococcal vaccines for preventing otitis media

    Masja M Straetemans;Elisabeth Am Sanders;Reinier H Veenhoven;Anne Gm Schilder

  • Associations between pathogens in the upper respiratory tract of young children: interplay between viruses and bacteria.

    Menno R. van den Bergh;Giske Biesbroek;John W. A. Rossen;Wouter A. A. de Steenhuijsen Piters

  • Dysbiosis of upper respiratory tract microbiota in elderly pneumonia patients

    Wouter A A de Steenhuijsen Piters;Elisabeth G W Huijskens;Elisabeth G W Huijskens;Anne L Wyllie;Giske Biesbroek

  • Rationale and design of CAPITA : a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults

    Eelko Hak;D E Grobbee;E A M Sanders;T J M Verheij

  • Bacterial and viral respiratory tract microbiota and host characteristics in children with lower respiratory tract infections : a matched case-control study

    Wing Ho Man;Marlies A van Houten;Marieke E Mérelle;Arine M Vlieger

  • Refined characterization and reference values of the pediatric T- and B-cell compartments.

    R. van Gent;C.M. van Tilburg;E.E. Nibbelke;S.A. Otto

  • Influenza- and respiratory syncytial virus-associated mortality and hospitalisations.

    A G S C Jansen;E A M Sanders;A W Hoes;A M van Loon

  • A host-protein based assay to differentiate between bacterial and viral infections in preschool children (OPPORTUNITY): a double-blind, multicentre, validation study.

    Chantal B van Houten;Joris A H de Groot;Adi Klein;Isaac Srugo

  • Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial.

    Elske J. M. van Gils;Reinier H. Veenhoven;Eelko Hak;Gerwin D. Rodenburg

  • Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands.

    Gerwin D. Rodenburg;Sabine C. de Greeff;Angelique G. C. S. Jansen;Hester E. de Melker

Frequent Co-Authors

Debby Bogaert
Debby Bogaert University of Edinburgh
Guy A. M. Berbers
Guy A. M. Berbers University of Minnesota
Arie van der Ende
Arie van der Ende University of Amsterdam
Hester E. de Melker
Hester E. de Melker National Institute of Public Health and the Environment (RIVM)
Ger T. Rijkers
Ger T. Rijkers University College Roosevelt
Eelko Hak
Eelko Hak University of Groningen
Krzysztof Trzciński
Krzysztof Trzciński Utrecht University
Marc J. M. Bonten
Marc J. M. Bonten Utrecht University
Louis Bont
Louis Bont Utrecht University
Diederick E. Grobbee
Diederick E. Grobbee Utrecht University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond Immunology, exploring related online degrees can provide valuable career opportunities. Nurses and healthcare professionals often look into programs such as accelerated FNP programs to transition quickly into family nurse practitioner roles. These programs offer a focused curriculum designed for efficient career advancement.

Additionally, obtaining acute care NP certification is a strategic step for nurse practitioners aiming to specialize in acute care settings. This certification expands clinical skills and opens doors to high-demand, specialized roles in healthcare.

For individuals without a nursing background, online accelerated nursing programs for non nurses offer a fast-track solution to enter the nursing field and ultimately pursue advanced degrees related to Immunology or other specialties.

Understanding potential earnings is also critical for career planning. Information on dnp salary by specialty can help guide decisions about which specialization aligns with both passion and financial goals. Together, these resources provide a comprehensive roadmap for advancing a career connected to Immunology and healthcare.

Best Scientists Citing Elisabeth A. M. Sanders

Trending Scientists

Recently Published Articles